🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

GV Venture Partner and psychiatrist Ben Robbins talks with Quartet Health and Lyra about mental health in 2020 – gv.com/news/mental-he…

Congrats to Andrew and the Headway team!

Congrats Andrew and the Headway team!

Getting people access to mental health support has never been more critical. I'm excited to continue to get behind @try_Headway as they work to expand access. techcrunch.com/2021/05/04/hea…

🚨The latest Second Opinion is out!🚨 I teamed up with GV's Dr. Ben Robbins for a major review of behavioral health today: Where is the space going, where the gaps are & what needs to happen next. Thoughts & feedback are welcome, as always! ovsecondopinion.substack.com/p/our-prescrip…

GV venture partner and psychiatrist Ben Robbins teams up with Second Opinion's Christina Farr to explore what's next for behavioral health — ovsecondopinion.substack.com/p/our-prescrip…

Honored to have the inspiring Ben Robbins, Venture Partner at GV, on to our podcast Physicians Off the Beaten Path Podcast . A must-listen episode for any clinician or otherwise interested in investing and innovation. #potbppodcast

I am honored to take on the role of general partner at GV. Thanks to FierceHealthcare’s Heather Landi for taking the time to chat with me, and to the founders of Waltz Health and Headway for the kind words. fiercehealthcare.com/health-tech/gv…

As part of our ongoing commitment to life sciences innovation, we’re excited to support Protas as they work towards greater efficiency in clinical trials for common diseases. David Schenkein Martin Landray spoke with Endpoints News about today’s news — bit.ly/3PDbiH7

“Our interests are broad, and we’re especially interested in companies at the intersection of health and technology.” Learn more about GV’s approach to moving healthcare forward in Forbes — bit.ly/3PE48mh

Culinary power couple, Joe and Shaina Papach are the owners of The Harvey House in Madison, Wisconsin, a restaurant that’s a celebration of the state’s iconic supper clubs and aims to be at the center of dining in Madison and beyond. #TheDish

The community of people willing to take the risk of starting value-based healthcare companies is growing, and it's promising to see new startups address areas like serious mental illness. Thanks @LauraLovett7 Behavioral Health Business for taking the time to chat — bhbusiness.com/2022/09/09/gv-…

The Founders Choice VC ranking got us curious.. so we ran the data in Notus 💬 for a ranking on which VC funds get the most social engagement: 1 Y Combinator 2 GV 3 Collab Fund 4 a16z 5 Kleiner Perkins 6 Sequoia Capital 7 Samsung Next 8 500 Global 9 Techstars 10 Accel

firsthand's founding team is mission-driven, serving underserved people with Serious Mental Illnesses (SMI). We're thrilled to officially welcome firsthand to the @gvteam portfolio as they create life-changing outcomes for individuals with SMI — bhbusiness.com/2023/02/06/goo…

Thanks to Heather Landi for chatting with me about Clever Care Health Plan’s mission to provide more inclusive Medicare options for patient impact. GV is excited to invest in Clever Care as they take a new approach to holistic healthcare — fiercehealthcare.com/payers/clever-…

To celebrate #MentalHealthAwareness Month and highlight efforts to create more accessible mental healthcare, GV General Partner Ben Robbins joined Headway to ring the Nasdaq opening bell! Read Headway’s mission to create affordable mental healthcare— bit.ly/3BAJsHc

Thrilled to be included alongside the Headway team yesterday at the Nasdaq opening bell ceremony! #MentalHealthAwareness

The owners of The Harvey House will be opening Butterbird, a chicken-focused restaurant, in January. buff.ly/3u4DbCY

Congratulations to Brightline, Caraway, CareBridge, Midi Health, Oasis, and Rippl for being recognized on Business Insider's Healthcare Startups to Watch list 🎉 GV’s Ben Robbins shares insights about promising companies on the list — bit.ly/48oUYUu

We’re incredibly excited to congratulate our longtime friend and colleague Anthony Philippakis as GV’s newest general partner. Congratulations! biopharmadive.com/news/gv-anthon…